Detalles de la búsqueda
1.
Effects of rifampin, itraconazole and esomeprazole on the pharmacokinetics of alisertib, an investigational aurora a kinase inhibitor in patients with advanced malignancies.
Invest New Drugs
; 36(2): 248-258, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28852909
2.
Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry.
Eur J Pediatr
; 171(6): 911-9, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22234477
3.
Phase 1 Study to Evaluate the Effect of the Investigational Anticancer Agent Sapanisertib on the QTc Interval in Patients With Advanced Solid Tumors.
Clin Pharmacol Drug Dev
; 9(7): 876-888, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32488989
4.
Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease.
Genet Med
; 11(3): 210-9, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19287243
5.
Characterizing the Sources of Pharmacokinetic Variability for TAK-117 (Serabelisib), an Investigational Phosphoinositide 3-Kinase Alpha Inhibitor: A Clinical Biopharmaceutics Study to Inform Development Strategy.
Clin Pharmacol Drug Dev
; 8(5): 637-646, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30168905
6.
Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib in Adult Patients With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic Dysfunction.
J Clin Pharmacol
; 59(9): 1204-1215, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30985952
7.
High rate of postoperative mortality in patients with mucopolysaccharidosis I: findings from the MPS I Registry.
J Pediatr Surg
; 47(3): 477-84, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22424341
Resultados
1 -
7
de 7
1
Próxima >
>>